Tabula Rasa HealthCare, now rebranded as AnewHealth, leverages advanced technology to enhance healthcare outcomes for complex patient populations. Their MedWise® Science technology is a key component, designed to identify cumulative multi-drug interactions and assign a MedWise Risk Score™. This innovative approach aids pharmacists in minimizing medication-related risks, thereby improving patient safety and care efficiency. Additionally, AnewHealth's CareKinesis, a PACE pharmacy service, offers a comprehensive suite of technology-driven pharmacy solutions, including 24/7 clinical support from board-certified geriatric pharmacists and personalized medication packaging.

The company also emphasizes the importance of pharmacogenomics (PGx) testing, which evaluates how individual patients respond to medications based on their genetic makeup. This testing allows pharmacists to assess drug-gene interactions and optimize medication regimens tailored to each participant's unique needs. By integrating these technologies into their services, AnewHealth aims to reduce hospitalizations and care costs while ensuring that patients receive the most effective and safe medication therapies.

United States

The Tabula Rasa HealthCare family of companies provide new beginnings for our clients, through innovative service models and fresh approaches to healthcare technology. Our leaders understand that to maximize patient experiences and outcomes, they must help providers to balance efficiency and scalability with safety and individualization of care.

Tabula Rasa HealthCare

Company Details